Greber, Basil J.
Boehringer, Daniel
Leibundgut, Marc
Bieri, Philipp
Leitner, Alexander
Schmitz, Nikolaus
Aebersold, Ruedi
Ban, Nenad
Article History
Received: 23 July 2014
Accepted: 26 September 2014
First Online: 1 October 2014
Competing interests
: CFI–ETH Zürich has filed a patent application to use the coordinates of the 39S mitoribosomal subunit for development of compounds that can (1) specifically bind to the mitochondrial ribosome and interfere with mitochondrial translation or (2) specifically inhibit translation of pathogenic organisms without interfering with mitochondrial translation.